Make a Gift
College of Health Sciences
Healthcare Professionals
Volunteering
MyChart Login
Clinical Trials
Career Opportunities
Contact Us
≡
Medical Services
Find a Provider
Patients & Visitors
Classes & Events
Clinical Trials
Contact a Patient
Dining
Donate Blood
Parking
Patient Feedback
Pay Bills Online
Pricing Transparency
Visiting Hours
MyChart Login ›
Report Sexual Misconduct ›
Locations
News & Blog
News & Stories
Live Well Blog
Live Well Magazine
Webinars
Subscribe to Newsletter
Coronavirus FAQ
Events
About Us
About UCI Health
340B Program
Classes & Events
Community Health
Compliance
Contact Us
Giving
Human Resources
News
Nondiscrimination
Planning Administration
Publications
Quality & Safety
Virtual Tour
Volunteering
Site Search
Site Search
Home
›
Clinical Trials
›
Cancer Clinical Trial
›
Colon
›
(CIRB) A Phase II/III Trial of Neoadjuvant FOLFOX with Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection with Total Mesorectal Excision
Print
A
A
A
COVID-19 vaccine and protecting your health ›